bimekizumab
ucb pharmaceuticals
['bimekizumab', 'axspa']
bimekizumab (il-17a and il-17f inhibitor) use in non-radiographic axspa resulted in rapid improvement of asas40 along with reduction in sparcc mri si joint inflammation
#abs0544 #acr22 
Rheumatologist. Amateur chef. YNWA. Views and opinions are my own.